Nov. 16, 2016--E-cigarette use among teenagers is growing dramatically, and public health experts are concerned that these devices may be a gateway to smoking. Now, new research indicates that even if these young e-cigarette users do not become tobacco smokers, e-cigarettes may harm their health.
In "Electronic-cigarette Use and Respiratory Symptoms in Adolescents," published online ahead of print in the American Thoracic Society's American Journal of Respiratory and Critical Care, lead author Rob McConnell, MD, professor of preventive medicine at the Keck School of Medicine at the University of Southern California, and colleagues report an association between e-cigarette use and persistent cough, bronchitis and congestion or phlegm in the Southern California Children's Health Study.
"E-cigarettes are known to deliver chemicals toxic to the lungs, including oxidant metals, glycerol vapor, diketone flavoring compounds and nicotine," Dr. McConnell said. "However, there has been little study of the chronic health effects of e-cigarettes. The Children's Health Study provided an opportunity to examine bronchitic symptoms common among smokers to see if the risk was also increased in users of e-cigarettes."
The researchers analyzed responses to a 2014 questionnaire completed by 2,086 study participants. Investigators categorized respondents as never e-cigarette users (76%), past users (more than 30 days earlier, 14.4%) and current users (at least once within the past 30 days, 9.6%).
The study found that when compared to those who never tried e-cigarettes, the risk of the respiratory symptoms was
- approximately 85 percent higher among past users, and
- double among current users
These associations remained statistically significant for past users after being adjusted for smoking and secondhand tobacco smoke exposure and sociodemographic factors. The researchers also looked at wheeze, a narrowing of the airways often caused by an asthma exacerbation, but did not find a significant association with e-cigarettes after adjusting for the same confounding factors.
"The Food and Drug Administration recently banned the sale of e-cigarettes to children under 18 years of age, and California just prohibited sale to young adults under 21," Dr. McConnell said. "Our results suggest that these regulations and an environment that discourages the initiation of any tobacco product may reduce the burden of chronic respiratory symptoms in youth. However, because e-cigarettes are relatively new, additional study is needed to fully understand their long-term effects."
Begun in 1992, the Southern California Children's Health study has enrolled more than 11,000 children in one of the largest and most detailed studies of the long-term effects of air pollution on the respiratory health of children.
Share via Twitter
"Researchers find #e-cigarettes pose harm to teens beyond being gateway to smoking."
About the American Journal of Respiratory and Critical Care Medicine (AJRCCM):
The AJRCCM is a peer-reviewed journal published by the American Thoracic Society. The Journal takes pride in publishing the most innovative science and the highest quality reviews, practice guidelines and statements in pulmonary, critical care and sleep medicine. With an impact factor of 12.996, it is the highest ranked journal in pulmonology. Editor: Jadwiga Wedzicha, MD, professor of respiratory medicine at the National Heart and Lung Institute (Royal Brompton Campus), Imperial College London, UK.
About the American Thoracic Society:
Founded in 1905, the American Thoracic Society is the world's leading medical association dedicated to advancing pulmonary, critical care and sleep medicine. The Society's 15,000 members prevent and fight respiratory disease around the globe through research, education, patient care and advocacy. The ATS publishes three journals, the American Journal of Respiratory and Critical Care Medicine, the American Journal of Respiratory Cell and Molecular Biology and the Annals of the American Thoracic Society.
The ATS will hold its 2017 International Conference, May 19-24, in Washington, DC, where world-renowned experts will share the latest scientific research and clinical advances in pulmonary, critical care and sleep medicine.